HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
Kingmaker (01170) spent HK$148,600 to repurchase 176,000 shares on March 4th.
04/03/2025
GMT Eight
KINGMAKER (01170) announced on March 4, 2025, that the company would spend 148,600 Hong Kong dollars to repurchase 176,000 shares.
Subsidiary company "Human Coagulation Factor IX" of Beijing Tiantan Biological Products Corporation (600161.SH) will conduct phase III clinical trials.
HSBC Holdings (00005) spent approximately 270 million Hong Kong dollars to repurchase 2.948 million shares on March 3rd.
RECOMMEND
Ping An Insurance Group has increased its holdings in China Merchants Bank by 12.482 million shares, with a price of approximately 45.81 Hong Kong dollars per share.
7 min ago
Nanxing Machinery (002757.SZ): Nanxing Investment and Zhan Rening jointly reduced their holdings by 3%
8 min ago
Shandong Nanshan Aluminium (600219.SH): Shandong Nanshan Aluminium International has submitted the hearing material set to the Hong Kong Stock Exchange.
10 min ago
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com